You are viewing: North America Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The North America Latent TB Testing Market was valued at $209.3 Million in 2024 and projected to reach to $239.8 Million by 2029, representing a compound annual growth rate of 2.8%. North America's latent TB testing market demonstrates stable growth supported by mature healthcare systems, regulatory compliance requirements, and established clinical protocols.

North America Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Latent TB Testing Market Trends and Insights

  • North America's mature healthcare infrastructure and established diagnostic capabilities support steady adoption of latent TB testing technologies across clinical and occupational health settings.
  • In North America, regulatory frameworks and reimbursement policies continue to drive market penetration, particularly among high-risk populations including healthcare workers, immigrants, and immunocompromised individuals. Growth in the North America latent TB testing market is tempered by the region's lower TB incidence compared to global hotspots, yet North America remains a significant market due to robust healthcare spending and advanced laboratory networks.
  • Between 2024 and 2029, North America will see incremental adoption of newer interferon-gamma release assays (IGRAs) and point-of-care testing solutions.
  • North America's focus on TB elimination strategies and occupational health compliance ensures sustained demand for latent TB diagnostics throughout the forecast period..

Key Market Statistics

  • CAGR (2024-2029) 2.8% CAGR
  • Market Size, 2024 ~USD 209.3 Million
  • Forecast, 2029 ~USD 239.8 Million
  • Geography North America

North America Latent TB Testing Market Overview

Dominant US Market Leadership :

The US represents 90.6% of North America's latent TB testing market at $189.58 million in 2024, driven by robust healthcare infrastructure, mandatory occupational screening programs, and high diagnostic adoption rates across hospitals and clinics.

Steady Growth Trajectory :

North America's latent TB testing market is projected to grow from $209.3 million in 2024 to $239.8 million by 2029 at a 2.8% CAGR, reflecting consistent demand from healthcare facilities and occupational health providers.

Mature Healthcare Infrastructure :

Established diagnostic capabilities and advanced laboratory networks across North America support widespread adoption of latent TB testing technologies, including interferon-gamma release assays and tuberculin skin tests.

Canada's Complementary Market :

Canada contributes $24.85 million to the regional market, with strong public health initiatives and immigration screening requirements driving consistent demand for latent TB diagnostic solutions.

North America Latent TB Testing Market Dynamics

  • The region benefits from high awareness of TB prevention, mandatory screening in occupational and immigration contexts, and integration of advanced diagnostic technologies into standard care pathways.
  • Healthcare providers across the US and Canada continue to invest in reliable latent TB detection methods to support public health objectives and workplace safety standards. Looking ahead to 2029, the market will be shaped by technological advancements in rapid testing platforms, increasing adoption of point-of-care diagnostics, and sustained demand from occupational health programs.
  • While growth rates remain moderate compared to emerging markets, North America's established infrastructure ensures consistent market expansion driven by regulatory mandates, healthcare facility upgrades, and ongoing TB elimination initiatives..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • North America's latent TB testing market is valued at $209.3 million in 2024 with projected growth to $239.8 million by 2029.
    • North America exhibits a moderate 2.8% CAGR, reflecting mature market dynamics and lower TB incidence relative to endemic regions.
    • North America's healthcare infrastructure and occupational health regulations drive consistent demand for latent TB diagnostics.
    • North America will experience gradual adoption of advanced IGRA technologies and point-of-care testing solutions through 2029.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    North America Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    Target Audience

    • Diagnostic Device Manufacturers : Need regional market data to assess North America's mature diagnostic market, plan product positioning for TB testing platforms, and identify growth opportunities in occupational health segments.
    • Healthcare System Administrators : Require market insights to justify TB testing program investments, benchmark diagnostic spending against regional standards, and optimize screening protocols across clinical facilities.
    • Occupational Health Providers : Depend on market intelligence to understand workplace TB screening demand, evaluate testing technology options, and align service offerings with employer compliance requirements across North America.
    • Investment and Private Equity Firms : Seek regional market analysis to evaluate acquisition targets in the latent TB testing sector, assess growth potential in mature North American healthcare markets, and identify consolidation opportunities.
    • Public Health Agencies : Use market data to inform TB elimination strategies, allocate screening resources efficiently, and understand diagnostic technology adoption trends supporting regional public health objectives.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 183.6 Million · 6.5% wtd CAGR ·
    Asia Pacific
    ~USD 298.7 Million · 8.1% wtd CAGR ·
    Latin America
    ~USD 44.9 Million · 7.4% wtd CAGR ·
    Middle East & Africa
    ~USD 6.4 Million · 5.7% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 189.58 Million
    CanadaUSD 24.85 Million

    Country market size visualization

    US
    USD 189.58 Million
    Canada
    USD 24.85 Million

    Reasons to Buy this Report

    • Precise Regional Market Sizing : Access detailed market valuations for North America ($209.3M in 2024) with country-level breakdowns for the US and Canada, enabling accurate budget allocation and competitive positioning strategies.
    • Growth Forecasting Through 2029 : Leverage 5-year projections showing expansion to $239.8M at 2.8% CAGR to plan product launches, market entry strategies, and resource investments aligned with regional demand trajectories.
    • Occupational Health Insights : Understand North America's unique occupational screening requirements and workplace TB testing protocols that drive consistent demand across healthcare, manufacturing, and public sector employers.
    • Competitive Landscape Analysis : Identify market dynamics specific to mature North American healthcare systems, including diagnostic technology adoption patterns, regulatory compliance drivers, and key customer segments.
    • Strategic Market Intelligence : Benchmark performance against regional growth rates (2.8% vs. global 5.8%) to assess market saturation levels and identify opportunities for differentiation in established healthcare markets.

    Frequently asked questions

    What is the current size of the latent TB testing market in North America?

    The North America latent TB testing market was valued at $209.3 million in 2024 and is expected to reach $239.8 million by 2029.

    What is the growth rate for latent TB testing in North America?

    North America's latent TB testing market is growing at a compound annual growth rate (CAGR) of 2.8% from 2024 to 2029.

    Which populations drive latent TB testing demand in North America?

    North America's latent TB testing demand is primarily driven by healthcare workers, immigrants, immunocompromised individuals, and occupational health compliance requirements.

    What testing technologies are prevalent in North America's latent TB market?

    North America's latent TB testing market is dominated by interferon-gamma release assays (IGRAs), with emerging adoption of point-of-care testing solutions.

    Why is North America's latent TB testing growth rate lower than the global average?

    North America's 2.8% CAGR reflects the region's lower TB incidence, mature diagnostic infrastructure, and established market saturation compared to endemic regions globally.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status